FR2495636B2 - Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn - Google Patents

Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn

Info

Publication number
FR2495636B2
FR2495636B2 FR808026132A FR8026132A FR2495636B2 FR 2495636 B2 FR2495636 B2 FR 2495636B2 FR 808026132 A FR808026132 A FR 808026132A FR 8026132 A FR8026132 A FR 8026132A FR 2495636 B2 FR2495636 B2 FR 2495636B2
Authority
FR
France
Prior art keywords
hepatitis
virus
transformation
cells
preparations containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR808026132A
Other languages
English (en)
Other versions
FR2495636A2 (fr
Inventor
Christine Pourcel
Anne Louise
Pierre Tiollais
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR808026132A priority Critical patent/FR2495636B2/fr
Priority to DE8181400634T priority patent/DE3176404D1/de
Priority to CA375917A priority patent/CA1341641C/fr
Priority to EP81400634A priority patent/EP0038765B1/fr
Publication of FR2495636A2 publication Critical patent/FR2495636A2/fr
Priority to US06/482,322 priority patent/US5314808A/en
Application granted granted Critical
Publication of FR2495636B2 publication Critical patent/FR2495636B2/fr
Priority to LU88364C priority patent/LU88364I2/fr
Priority to NL930133C priority patent/NL930133I2/nl
Priority to NL930132C priority patent/NL930132I1/nl
Priority to LU88363C priority patent/LU88363I2/fr
Priority to US08/191,133 priority patent/US5591638A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR808026132A 1980-04-22 1980-12-09 Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn Expired FR2495636B2 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR808026132A FR2495636B2 (fr) 1980-12-09 1980-12-09 Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
DE8181400634T DE3176404D1 (en) 1980-04-22 1981-04-22 Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
CA375917A CA1341641C (fr) 1980-04-22 1981-04-22 Expression d'un antigene de surface recombinant du vhb
EP81400634A EP0038765B1 (fr) 1980-04-22 1981-04-22 Vaccin contre l'hépatite virale B, procédé et cellules eucaryotes transformées pour la production de ce vaccin
US06/482,322 US5314808A (en) 1980-04-22 1983-04-05 Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs
LU88364C LU88364I2 (fr) 1980-04-22 1993-07-02 HBVax Vaccin recombinant contenant une protéine HBsAG pour une immunisation active contre des infections dues à l'hépatite B.
NL930133C NL930133I2 (nl) 1980-04-22 1993-07-02 Vaccin tegen hepatitis B virus, werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin.
NL930132C NL930132I1 (nl) 1980-04-22 1993-07-02 Vaccin tegen hepatitis B virus werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin
LU88363C LU88363I2 (fr) 1980-04-22 1993-07-02 Engerix b Vaccin recombinant contenant une protéine HBsAG pour une immunisation active contre des infections dues à l'hépatite B.
US08/191,133 US5591638A (en) 1980-04-22 1994-01-25 Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of B viral hepatitis, and preparations containing the expression products of said DNAs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR808026132A FR2495636B2 (fr) 1980-12-09 1980-12-09 Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn

Publications (2)

Publication Number Publication Date
FR2495636A2 FR2495636A2 (fr) 1982-06-11
FR2495636B2 true FR2495636B2 (fr) 1989-10-06

Family

ID=9248858

Family Applications (1)

Application Number Title Priority Date Filing Date
FR808026132A Expired FR2495636B2 (fr) 1980-04-22 1980-12-09 Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn

Country Status (1)

Country Link
FR (1) FR2495636B2 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU88257I2 (fr) * 1978-12-22 1994-02-03

Also Published As

Publication number Publication date
FR2495636A2 (fr) 1982-06-11

Similar Documents

Publication Publication Date Title
EP0626998A4 (fr) Production de plantes resistant a des virus par introduction d'arn viral de non translation a sens positif.
OA06416A (fr) Procédé de production d'un ADN comprenant le genome du virus de l'hépatite B et vecteur le comportant.
FR2480780B1 (fr) Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
OA07991A (fr) Dérivés de nitrométhylène, produits intermédiaires correspondants, leur procédé de production et insecticides contenant ces dérivés.
YU140380A (en) Process for obtaining dna fragment of hepatitis b virus
IT8267522A0 (it) Procedimento per la produzione di dna complementare rappresentante sequenze virali di rna mediante metodi del dna ricombinante prodotti relativi e loro usi
OA07103A (fr) Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
IT7920867A0 (it) Procedimento di produzione di percettori di gas d'ossigeno.
OA07172A (fr) Nouvelles thiazolidinediones, leur procédé de production et préparation pharmaceutique les contenant.
OA06915A (fr) Procédé de récupération séparée du molybdène et du vanadium.
BE871770A (fr) Nouveaux derives de phtalazine, leur procede de production et composition pharmaceutique les contenant
IL57596A (en) Process for the purification and concentration of urokinase
EP0182442A3 (en) Recombinant DNA molecules and their method of production.
FR2495636B2 (fr) Procede de transformation de cellules, notamment eucaryotes, par un fragment d'adn circulaire du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
EP0592685A4 (fr) Vegetal resistant a au moins deux virus et sa preparation.
IT8049362A0 (it) Procedimento per la produzione di 7-alcossicarbonil-6,8-dimetil-4idrossimetil-1-ftalazone e relativi prodotti intermedi
OA06776A (fr) Procédé de préparations pharmaceutiques.
OA05233A (fr) Procédé de préparation d'acides (7-acétamido Disubstitue)-3- substitue-3- cephem-4-carboxyliques et nouveaux produits industriels.
ZA824376B (en) Process for extracting, concentrating and purifying natural aromas of plant origin and products obtained by this process
OA08414A (fr) Alcènes nouveaux, leur procédé de préparation et leurs applications pour combattre des insectes.
ATE112313T1 (de) Nitrat-reduktase-strukturgen enthaltender klonierungsvektor.
FI98466B (fi) FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi
GB2029406B (en) Process for the manufacuture of cyclic acetals of aliphatic aldehydes
OA06331A (fr) Nouveaux esters du méthyl-1 pipéridinol-3, et leur procédé de préparation.

Legal Events

Date Code Title Description
CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0398, 920604

CC Supplementary protection certificate (spc) laid open to the public (law of 25 june 1990)

Free format text: 92C0468, 920622

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0398, 801209

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0468, 801209

CB Supplementary protection certificate (spc) granted (law of 25 june 1990)

Free format text: 92C0467, 801209

CP Supplementary protection certificate (spc) filed